The UK Government and the Association of the British Pharmaceutical Industry (ABPI) have agreed to accelerate the planned review of the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).
The Equality and Human Rights Commission (EHRC) has published an interim update on the practical implications of the Supreme Court's judgment in For Women Scotland v Scottish Ministers.
The Court of Appeal has clarified when the absence of historic records might justify drawing adverse inferences, offering helpful reminders for employers about evidential risks, record-keeping practices, and statutory compliance.